MIT researchers introduce CuRVE, a protein-labeling technique enabling uniform staining across entire tissues.

A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals ...

In this manuscript the authors established a novel three-dimensional culture system for stratified epithelia that allows epithelial cells to undergo epithelial-to-mesenchymal transition (EMT) and ...

BENGALURU: When the first outbreak happened in Pune, all heads turned and started to panic. What was this new infectious ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.

In the field of biopharmaceuticals, every technological innovation has the potential to revolutionize treatment strategies. Sanyou Bio's Intelligent Hundred-Trillion Molecule Library (AI-STAL) has ...

A new study shows how an anticancer drug triggers an 'outside in' signal that gets it sucked into a cancer cell. The work reveals a new signaling mechanism that could be exploited for delivering other ...

A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell.

P-cadherins are cell adhesion proteins that are overexpressed in cancers. This study offers insights into the regulation of cell adhesion and the design of drug delivery antibodies by showing that ...

GBS begins with tingling or numbness in the feet and hands, followed by muscle weakness and difficulty moving joints.

Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...